Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 12, 2021 / 06:00PM GMT
Release Date Price: €86.76 (-2.08%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Welcome. Thank you so much for joining us virtually. It's a pleasure having you here and talking to you, as always. For folks in the audience who don't know, on the screen there, on the top right, is John Sheridan, who's the President and CEO of Tandem; top left is Leigh Vosseller, who's the EVP and CFO; and then on the bottom is Susan Morrison, who is the CAO and runs Investor Relations as well.

So we're going to have a 45-minute fireside chat with the team. And as always, if you want to ask questions through the iPad, just use the instructions on your table.

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

So I'll kick things off with just a high-level question. Why don't you give us an overview on some of the business trends? Talk about how the business has been performing, and any update on recent trends you can provide

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot